NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Kardium Inc.

Kardium Inc.

Private
BurnabyHealthcare & Life Scienceshttps://kardium.com/

Last Round

Series D

Jul 2, 2025

Total Funding Raised

$410.05M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Kardium Inc. is a medical technology company that develops and markets advanced diagnostic and ablation systems for the treatment of atrial fibrillation.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

atrial fibrillationpulsed field ablationPFAcardiac ablationelectrophysiologypulmonary vein isolationPVImedical deviceablation cathetercardiac mappingheart rhythm treatmentelectrophysiology labAFib treatmentEP lab

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Kardium Inc. Comparables

Compare Kardium Inc. with similar companies based on industry and business-model similarity.

Kardium Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CardioFocus
84%
Johnson & Johnson
83%
MedLumics
83%

Kardium Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DJul 2, 2025
VC RoundJun 11, 2024
DebtJan 9, 2024
GrantMay 31, 2022
Series DJan 25, 2021
Series A
Feb 7, 2019

Key People

Founding team and executive leadership

Kevin Chaplin

CEO

Executive Team

Koert VandenEnden

Chief Financial Officer

Executive Team

Kardium Inc. Investors

Notable investors and investment history

Kardium Inc. investors
InvestorRounds
MMCAP VenturesSeries D
Janus Henderson GroupSeries D
EckuitySeries D
Durable Capital Partners LPSeries D, VC Round
Eventide FundsSeries D
Fidelity Management & Research CompanySeries D, VC Round
T. Rowe PriceSeries D, VC Round, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    Globe Pulsed Field System receives FDA approval and begins commercial launch.

  • Oct 10, 2025

    Leased 225,000 sq ft across ten buildings.

Kardium Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Kardium Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Kardium Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersBurnaby
Employee Range636
Year Founded2007
Last FundingJul 2, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.